Nancy Lurker - 02 Jul 2025 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role: Director
Signature: /s/ Ron Honig, Attorney-in-Fact
Issuer symbol: EYPT
Transactions as of: 02 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 02 Jul 2025, 16:05:58 UTC
Previous filing: 02 Jun 2025
Next filing: 11 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lurker Nancy	Director	C/O EYEPOINT PHARMACEUTICALS, INC., 480 PLEASANT STREET, WATERTOWN	/s/ Ron Honig, Attorney-in-Fact	02 Jul 2025	0001450485

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	-31,165	-100%	$0.000000	0	02 Jul 2025	Common Stock	31,165	$13.13	Direct	F1, F2
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	+31,165	+17%	$0.000000	213,700	02 Jul 2025	Common Stock	31,165	$13.13	By Family Trust	F1, F2, F3
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	-55,000	-58%	$0.000000	40,000	02 Jul 2025	Common Stock	55,000	$10.13	Direct	F1, F4
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	+55,000	+38%	$0.000000	200,000	02 Jul 2025	Common Stock	55,000	$10.13	By Family Trust	F1, F3, F4
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	-103,308	-37%	$0.000000	178,442	02 Jul 2025	Common Stock	103,308	$3.26	Direct	F1, F5
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	+103,308	+61%	$0.000000	272,358	02 Jul 2025	Common Stock	103,308	$3.26	By Family Trust	F1, F3, F5
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	-15,278	-31%	$0.000000	34,722	02 Jul 2025	Common Stock	15,278	$9.11	Direct	F1, F6
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	+15,278	+92%	$0.000000	31,944	02 Jul 2025	Common Stock	15,278	$9.11	By Family Trust	F1, F3, F6
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	-27,270	-35%	$0.000000	49,730	02 Jul 2025	Common Stock	27,270	$20.40	Direct	F1, F7
transaction	EYPT	Stock Option (Right to Buy)	Gift	$0	+27,270		$0.000000	27,270	02 Jul 2025	Common Stock	27,270	$20.40	By Family Trust	F1, F3, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 2, 2025, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share ("Common Stock"), of EyePoint Pharmaceuticals, Inc. (the "Company"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the "Family Trust").
F2	The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full.
F3	These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4	The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026.
F5	The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 6, 2027.
F6	The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until July 10, 2027.
F7	The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until January 5, 2028.